Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 25NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Radiotherapy 10Early Intervention, Educational 7Standard of Care 6Magnetic Resonance Spectroscopy 6Interviews as Topic 6Educational Status 6Radiotherapy, Conformal 5Practice Guidelines as Topic 5Methods 5Cyclophosphamide 5Vincristine 4Psychiatric Rehabilitation 4Cisplatin 4Brachytherapy 4Biopsy 4Surgical Procedures, Operative 3Specimen Handling 3Radiosurgery 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Dexamethasone 3Counseling 3Carboplatin 3pegaspargase 2motexafin gadolinium 2etoposide phosphate 2Radiofrequency Ablation 2Radiation 2Preoperative Exercise 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × NETWORK × venetoclax × Clear all
NCT06237192 2024-02-01

MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult Patients

National Research Center for Hematology, Russia

Phase NA Recruiting
200 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡